Stockreport

Assessing ImmunityBio (IBRX) Valuation After Positive ANKTIVA Lung Cancer Trial Results [Yahoo! Finance]

ImmunityBio, Inc.  (IBRX) 
PDF suggesting meaningful immune restoration and survival links in heavily treated patients. See our latest analysis for ImmunityBio. The ANKTIVA update and ImmunityBio' [Read more]